Literature DB >> 31335148

Antibodies Irreversibly Adsorb to Gold Nanoparticles and Resist Displacement by Common Blood Proteins.

Guadalupe Ruiz1, Nicki Ryan1, Kylie Rutschke1, Olatunde Awotunde1, Jeremy D Driskell1.   

Abstract

Gold nanoparticles (AuNPs) functionalized with proteins to impart desirable surface properties have been developed for many nanobiotechnology applications. A strong interaction between the protein and nanoparticle is critical to the formation of a stable conjugate to realize the potential of these emerging technologies. In this work, we examine the robustness of a protein layer adsorbed onto gold nanoparticles while under the stress of a physiological environment that could potentially lead to protein exchange on the nanoparticle surface. The adsorption interaction of common blood plasma proteins (transferrin, human serum albumin, and fibrinogen) and anti-horseradish peroxidase antibody onto AuNPs is investigated by nanoparticle tracking analysis. Our data show that a monolayer of protein is formed at saturation for each protein, and the maximum size increase for the conjugate, relative to the AuNP core, correlates with the protein size. The binding affinity of each protein to the AuNP is extracted from a best fit of the adsorption isotherm to the Hill equation. The antibody displays the greatest affinity (Kd = 15.2 ± 0.8 nM) that is ∼20-65 times stronger than the affinity of the other plasma proteins. Antibody-AuNP conjugates were prepared, purified, and suspended in solutions of blood plasma proteins to evaluate the stability of the antibody layer. An enzyme-mediated assay confirms that the antibody-AuNP interaction is irreversible, and the adsorbed antibody resists displacement by the plasma proteins. This work provides insight into the capabilities and potential limitations of antibody-AuNP-enabled technologies in biological systems.

Entities:  

Year:  2019        PMID: 31335148     DOI: 10.1021/acs.langmuir.9b01900

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  7 in total

1.  Orientation-Controlled Bioconjugation of Antibodies to Silver Nanoparticles.

Authors:  Nicole E Pollok; Charlie Rabin; Leilani Smith; Richard M Crooks
Journal:  Bioconjug Chem       Date:  2019-11-15       Impact factor: 4.774

Review 2.  Nanoparticle Effects on Stress Response Pathways and Nanoparticle-Protein Interactions.

Authors:  Shana J Cameron; Jessica Sheng; Farah Hosseinian; William G Willmore
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

3.  Development of Neuropeptide Y and Cell-Penetrating Peptide MAP Adsorbed onto Lipid Nanoparticle Surface.

Authors:  Sara Silva; Joana Marto; Lídia M Gonçalves; Henrique S Fernandes; Sérgio F Sousa; António J Almeida; Nuno Vale
Journal:  Molecules       Date:  2022-04-24       Impact factor: 4.927

4.  Electrochemical Detection of NT-proBNP Using a Metalloimmunoassay on a Paper Electrode Platform.

Authors:  Nicole E Pollok; Charlie Rabin; Charuksha T Walgama; Leilani Smith; Ian Richards; Richard M Crooks
Journal:  ACS Sens       Date:  2020-03-10       Impact factor: 7.711

5.  Antibody-Functionalized Carnauba Wax Nanoparticles to Target Breast Cancer Cells.

Authors:  Banu Iyisan; Johanna Simon; Yuri Avlasevich; Stanislav Baluschev; Volker Mailaender; Katharina Landfester
Journal:  ACS Appl Bio Mater       Date:  2022-01-03

6.  Influence of particle size on the SARS-CoV-2 spike protein detection using IgG-capped gold nanoparticles and dynamic light scattering.

Authors:  C B P Ligiero; T S Fernandes; D L D'Amato; F V Gaspar; P S Duarte; M A Strauch; J G Fonseca; L G R Meirelles; P Bento da Silva; R B Azevedo; G Aparecida de Souza Martins; B S Archanjo; C D Buarque; G Machado; A M Percebom; C M Ronconi
Journal:  Mater Today Chem       Date:  2022-04-22

7.  Differential Refractometric Biosensor for Reliable Human IgG Detection: Proof of Concept.

Authors:  João P Mendes; Luís C C Coelho; Pedro A S Jorge; Carlos M Pereira
Journal:  Biosensors (Basel)       Date:  2022-07-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.